Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ELGX

Endologix

$0.54

0.0223 (4.27%)

10:25
02/22/19
02/22
10:25
02/22/19
10:25
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

OBLN

Obalon Therapeutics

$2.17

0.07 (3.33%)

08:29
02/22/19
02/22
08:29
02/22/19
08:29
Hot Stocks
Obalon Therapeutics announces first commercial shipment of navigation system »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 18

    May

OBLN

Obalon Therapeutics

$2.17

0.07 (3.33%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Earnings
Obalon Therapeutics reports Q4 EPS (39c), consensus (36c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 18

    May

INSM

Insmed

$25.57

-0.42 (-1.62%)

07:33
02/22/19
02/22
07:33
02/22/19
07:33
Hot Stocks
Insmed sees FY19 ARIKAYCE revenues $80M-$90M »

Insmed expects cash-based…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ELGX

Endologix

$0.52

-0.0223 (-4.09%)

04:55
02/22/19
02/22
04:55
02/22/19
04:55
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

Thursday
ELGX

Endologix

$0.52

-0.0223 (-4.09%)

21:09
02/21/19
02/21
21:09
02/21/19
21:09
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

CUTR

Cutera

$15.53

0.39 (2.58%)

07:54
02/21/19
02/21
07:54
02/21/19
07:54
Recommendations
Cutera analyst commentary at Stephens »

Cutera price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

Wednesday
CUTR

Cutera

$15.53

0.39 (2.58%)

16:16
02/20/19
02/20
16:16
02/20/19
16:16
Earnings
Cutera sees FY19 revenue 165M -$175M , consensus $172.1M »

Sees FY19 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Mar

CUTR

Cutera

$15.53

0.39 (2.58%)

16:14
02/20/19
02/20
16:14
02/20/19
16:14
Earnings
Cutera reports Q4 EPS 11c, consensus 15c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Mar

Tuesday
ASRT

Assertio Therapeutics

$4.41

0.05 (1.15%)

08:35
02/19/19
02/19
08:35
02/19/19
08:35
Hot Stocks
Assertio Therapeutics announces FDA acceptance for filing of 505 NDA »

Assertio Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.